GWM
SCYX icon

Geneos Wealth Management’s SCYNEXIS SCYX Stock Holding History

Geneos Wealth Management’s Portfolio SCYX Stock Details SCYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-225
Closed -$3.6K – 2611
2024
Q2 		$3.6K Buy
+225
New +$3.48K ﹤0.01% 1780

Other funds holding SCYX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's SCYX Position: Q3 2024 in Review

Geneos Wealth Management sold out of SCYNEXIS (SCYX) in Q3 2024, closing a stake of 225 shares — an estimated $3.6K sold.

Geneos Wealth Management first reported a position in SCYX in Q2 2024 and held it in 1 quarter. The position peaked at $3.6K in Q2 2024. 44 funds tracked by Wall St. Rank hold SCYX as of Q3 2024.

  • Geneos Wealth Management reported no remaining SCYNEXIS position as of Q3 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 225 SCYNEXIS shares in Q3 2024, an estimated $3.6K.
  • Geneos Wealth Management first reported a position in SCYNEXIS in Q2 2024 and held it in 1 quarter.
  • Geneos Wealth Management's SCYNEXIS position peaked at $3.6K in Q2 2024.
  • 44 funds tracked by Wall St. Rank held SCYNEXIS as of Q3 2024.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.